Company Filing History:
1 out of 41 
1 out of 12 Years Active: 2017
Title: Tsutomu Numata: Innovator in Therapeutic Solutions for Allergic Rhinitis
Introduction
Tsutomu Numata is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of medical therapeutics, particularly in the treatment of allergic rhinitis. His innovative approach focuses on providing safe and effective solutions for patients suffering from this condition.
Latest Patents
Numata holds a patent for a therapeutic agent designed to treat allergic rhinitis. This agent utilizes 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) to deliver treatment in a noninvasive manner. The therapeutic agent comprises 5-aminolevulinic acid or its derivatives, which are used in a locally applied solution form, a water-soluble ointment-dissolved form, or a jelly-dissolved form. This innovative treatment method aims to minimize side effects and physical distress for patients.
Career Highlights
Throughout his career, Tsutomu Numata has worked with reputable organizations, including Sbi Pharmaceuticals Co., Ltd. and the National Hospital Organization. His experience in these institutions has contributed to his expertise in developing therapeutic solutions.
Collaborations
Numata has collaborated with notable colleagues, including Tohru Tanaka and Katsushi Inoue. Their combined efforts have further advanced the research and development of innovative treatments in the medical field.
Conclusion
Tsutomu Numata's work in developing a therapeutic agent for allergic rhinitis showcases his commitment to improving patient care through innovation. His contributions to the field highlight the importance of research and collaboration in advancing medical treatments.